Objective: To test whether HIV is associated with brain large artery vulnerable intima.
Introduction
HIV-positive (HIVþ) individuals have a higher incidence of stroke than those without HIV. This association has been consistent across various cohorts representing different regions within the United States [1] [2] [3] and other countries [4] . While traditional risk factors among those with HIV increase the risk of stroke, the use of antiretroviral therapy (ART), HIV-associated vasculopathy, and opportunistic infections may play a role in stroke causation in this population [5] . Immunosuppression among those with HIV has also been associated with an incidence rate of stroke 2.7 times higher than in HIVinfected individuals who are not immunosuppressed [6] .
Most studies that evaluated HIV as a vascular risk factor controlled for possible confounders. It is known that vascular risk factors such as diabetes and hypertension may be over-represented among those with HIV [7] . Also, HIV populations in the United States are predominantly underserved, and this may add social determinants of vascular risk [8] . Whether the mechanism of stroke in those with HIV differs from those without HIV is less well known, given that the majority of studies have used administrative datasets to ascertain stroke [4] . Such datasets have, as a limitation, the lack of adjudication of stroke mechanisms. The variability in the samples used to study stroke has led to the inclusion of a broad range of stroke causes, which tend to vary by the underlying distribution of CD4 þ cell counts in the population. For example, the prevalence of intracranial large artery atherosclerosis (ILAA) is higher in samples with higher CD4 þ cell counts [6] compared to those with lower CD4 þ cell counts [9] . In a pathology-based study, we reported that the prevalence of stenosis was not significantly higher compared with sex and age-matched HIVÀ controls [10] .
Intracranial large artery atherosclerosis may lead to cerebrovascular events through either plaque rupture or endothelial vulnerability. Though both these processes can cause strokes, the underlying plaques that predispose to either mechanism differ. Plaques that are thought to cause thrombosis by endothelial vulnerability or erosion typically have more smooth muscles cells and proteoglycans [11] , smaller lipid cores [12] , larger luminal areas [13] , and are less likely to be calcified [13] . Increased plaque vulnerability in HIVþ patients has been previously found in the coronary arteries. However, some populations including women, younger patients, and smokers are more likely to generate thrombi after eroding the endothelium of their vessels [11] , which would also be possible in the HIVþ population.
In that context, we hypothesized that even if the prevalence of ILAA is not higher among those with HIV, the endothelium may be more vulnerable to erosion, making plaques more vulnerable to rupture and providing a substrate for coagulation. This could potentially explain the higher incidence of stroke events, despite a relatively similar prevalence of arterial disease.
Methods Sample
Autopsied cases from the Brain Arterial Remodeling Study (BARS) were included in this study. HIV cases were obtained mostly from the Manhattan HIV Brain Bank (MHBB; U24MH100931), whereas HIV-negative (HIVÀ) controls were collected from MHBB, the New York Presbyterian Brain Bank/Macedonia Tissue Collection, and the University of Miami Brain Endowment Bank. The characteristics of each brain bank, and also the characteristics of the cases by brain bank, have been reported elsewhere [14] . Demographic and risk factor information, including HIV and immune status, was gathered by self-report, performance of laboratory testing during MHBB study visits, and/or by review of the electronic medical record.
Processing of brain arteries
Brain large arteries forming the circle of Willis and the vertebral arteries were dissected from available cases after formalin fixation for at least 7 days. All the visualized arteries were extracted. The first segments of the supraclinoid internal carotid, middle, anterior, posterior, basilar, and vertebral arteries were identified, and a 5-mm cut was performed at their most proximal ends (after the bifurcation), and also the more distal ends (preceding a subsequent bifurcation). Each segment was labeled accordingly, embedded in paraffin, and sectioned in 6-micron cuts for staining with hematoxylin and eosin, Van Gieson (for elastin), Congo Red (for amyloid deposition), and trichrome and Sirius Red (for collagen visualization). Each artery was digitized with Olympus Soft Imaging Solutions software running on a high-speed, highresolution Olympus VS110 virtual slide scanning system (Olympus, Center Valley, Pennsylvania, USA), and a microscope with a 10Â objective lens under constant illumination with a 0.643 micron per pixel resolution. Each artery was assigned a phenotype as recommended by the revised American Heart Association (AHA) classification system [15] . For the purpose of this study, we segregated 'atherosclerotic' arteries as arteries with evident cholesterol deposition, either diffusely as in pathological intima thickening, or coalescent as in an atheroma, with or without a thin fibrous cap. Arteries with evidence of fibrosis and/or calcification without cholesterol deposition (i.e. fibrocalcific plaques) were not considered atherosclerotic for the purpose of this analysis, given lack of evident cholesterol deposition. The interreader and intrareader reliabilities of the categorical variables described above have been reported as moderate to good [15] [16] [17] [18] . In arteries with atheromas, we determined the atheroma area, the thickness of the fibrous cap separating the atheroma from the lumen, the percentage of the intima occupied by the atheroma, the number of atheromas in a given individual, whether the atheroma was located deep against the media, and whether the intima thickening extended around the total circumference of the lumen (Fig. 1) . Additionally, we calculated the wall thickness, lumen diameters, and the lumen-to-wall ratio using color thresholding with good to excellent reliability [19] .
Immunohistochemistry
A variety of immunohistochemical stains have been performed on vessels in the BARS collection, as previously described [20] . For each specimen, paraffin was removed from the sections by first applying xylene and graded alcohols and then rinsing with distilled water. Then, one of various antigen retrieval methods was used depending on the antigen of interest (described in the Supplemental Table 1 , http://links.lww.com/QAD/ B316). Primary and secondary antibodies were then applied and tailored to the antigen of interest (specific antibodies are described in Supplemental Table 1 , http:// links.lww.com/QAD/B316). For all specimens, we used an ABC kit at 1 : 50 dilution for 30 min at room temperature as a tertiary antibody (Vector Laboratories, #PK-6100; Vector Laboratories, Burlingame, California, USA). Slides were visualized after use of a diaminobenzidine chromogen (DAB visualization kit, DAKO Corp., #K3467) and hematoxylin counterstain. All staining was done at the Herbert Irving Cancer Center Molecular Pathology Laboratory at Columbia University.
Measures of intima vulnerability
In addition to the structural features of atheromas described above, we used immunohistochemical staining to assess other features of vulnerability. We determined whether the strongest staining for matrix metalloprotease (MMP)-2, MMP-3, and MMP-9 within the wall of an artery was found in the luminal aspect of the artery by visual rating while blinded to HIV status. We also determined whether an artery demonstrated staining for tissue inhibitors of MMP (TIMP)-1 and TIMP-2 that was in the lowest quartile of the arteries stained after adjusting for average pixel intensity, as previously described [21] . We then created an intima elastolytic score that combined the pro-elastolytic measures indicated by stronger MMP staining in luminal aspect of the intima and the lower antielastolytic measures indicated by whether an artery fell within the lowest staining of a TIMP quartile. The score ranged from 0 to 5, with a 5 indicating the greatest elastolytic potential, given the combined effects of MMPs, unopposed by TIMP-1 or TIMP-2 (Fig. 2) . The inclusion of high MMP staining and low TIMP staining in the elastolytic score was based on previous evidence which had found that MMP-3 and MMP-9 were found predominantly in vulnerable plaque and that MMP-2 was found more ubiquitously, but was accompanied by less of its inhibitors in vulnerable plaque [22] . We also created an intima inflammation score that assessed whether the intima had the strongest staining of CD3 þ cells, CD68
þ cells, and TNF-a. The score ranged from 0 to 3, with 3 implying greater lymphocytic and macrophage infiltration, and increased intimal production of TNF-a (Fig. 2) . We evaluated for intima apoptosis using activated caspase-3 staining because endothelial apoptosis is thought to be part of the erosion pathway [11] (Fig. 3 , in Supplemental material, http://links.lww.com/ QAD/B316). We rated intima neoangiogenesis by the presence of vascular channels in the intima, and confirmed these with factor VIII staining (Fig. 3 , in Supplemental material, http://links.lww.com/QAD/ B316). Neoangiogenesis was investigated because plaque vessels have been associated with plaque progression [23] . The reliability of the topographical staining distribution is discussed below.
Statistical analysis
We assessed inter-reader reliability in the sample by having each artery rated twice by two different readers who were blinded to HIV status and to each other's reads. First, we used Cochran's alpha and gamma correlation to assess the reliability of a series of scales. We proposed to visually rate the area of the artery with strongest brown staining for a given antibody, but detailed characterization of staining intensity within the intima or media was in general suboptimal. The best performing scale rated the arterial layer with the strongest staining. We then restricted further analyses to the location with the strongest staining and did not use the other variables. The same topographic description was used for TNF-a and factor VIII staining. The reliability of the CD68 þ and CD3 þ assessments has been previously described. The intraclass correlation coefficient for CD68 þ was 0.93 [20] . The kappa value for inter-rater reliability for CD3 þ T-cell presence vs. absence in the intima was k ¼ 0.59 (further detail provided in [24] ). We provided the descriptive statistics in percentages or mean AE standard deviation (SD), as indicated. We used hierarchical multilevel models to assess the association between HIV and measures of ILAA vulnerability (generalized linear models for binary and ordinal variables, with a binomial or Poisson binomial distribution as fitted and mixed linear models for continuous variables). We then stratified by CD4 þ cell count to assess an association with ILAA vulnerability because studies have found that the prevalence of ischemic stroke [2] and ILAA-related stroke [10] vary with CD4 þ cell count.
Three models were generated for the investigations in the association with HIV status and with CD4 þ cell count. The first model adjusted for age, sex, ethnicity, interadventitial diameter, and artifact variables. The second model adjusted for vascular risk factors, which would allow us to interpret the degree of confounding effects from modifiable risk factors. The last model added atherosclerosis to isolate endothelial vulnerability from the effects associated with atheromas.
We reported beta estimates and their 95% confidence intervals (CIs) for the associations found here. A P value of 0.05 was considered significant. The analysis was carried out with SAS software, version 9.4 (SAS Institute Inc., Cary, North Carolina, USA). HIV was associated with less intima neoangiogenesis in a model adjusting for demographics alone (B ¼ À1.55, CI À3.09; À0.01, P ¼ 0.05), but the association became nonsignificant after adjusting for demographics, vascular risk factors, and atherosclerosis. There was no association between HIV, either categorically or stratified by CD4 þ cell counts, with the intima inflammation score or with intima apoptosis (Table 2) .
Results

Demographics/baseline
Co-expression of intima vulnerability scores
In models adjusting for demographics, risk factors, and ILAA, intima elastolytic score was associated with intima apoptosis (B ¼ 0.23, CI 0.05; 0.41, P ¼ 0.01), but not with intima neoangiogenesis (B ¼ 0.09, CI À0.37, 0.56, P ¼ 0.69) nor intima inflammation score (B ¼ 0.03, CI À0.07; 0.12, P ¼ 0.55). Intima inflammation score, intima apoptosis, and intima neoangiogenesis were not mutually associated, independently of ILAA. There was no statistical interaction by HIV in any of these associations.
Discussion
People living with HIV/AIDS are at an increased risk of stroke compared to uninfected controls. Among this population, intracranial atherosclerosis is an important cause of stroke [10, 25] . Because the prevalence of pathologically-defined ILAA is not different between those with HIV compared to HIVÀ controls (after adjusting for appropriate risk factors), we hypothesized that intima vulnerability may differ among those with HIV and thus partially explain a higher rate of ILAArelated events. We presented here data partially validating our hypothesis. Supporting our hypothesis, we found that individuals with HIV, and especially those whose last CD4 þ cell count prior to death was cell count below 200 cells/ml, exhibit more intima connective tissue remodeling as suggested by the imbalance of MMPs and TIMPs. Specifically, there was relatively higher staining of MMP-2, MMP-3, and MMP-9 in the intima and the relatively less staining of tissue inhibitors of MMP-1 and MMP-2. Such an imbalance between MMP and their inhibitors suggests an enhanced elastolytic activity. This could indicate that individuals with HIVand CD4 þ below 200 cells/ml are more likely to have plaques vulnerable to rupture, or, in the absence of an atheroma, may be more likely to erode intima compared either to those with HIV and better immune status or to HIVÀ controls. In the setting of equivalent prevalence of atheromas between the two populations as we found in this study, the population with more vulnerable plaques, found here to be HIVþ individuals, would be expected to have more stroke events. In addition, in the hypercoagulable state found in HIV [26, 27] , the simple erosion of intima may be sufficient substrate for triggering in-situ thrombosis and potentially occluding the artery or embolizing distally, causing stroke. In fact, stroke due to hypercoagulable state is over-represented among those with HIV [9] . We did not find a significant difference by HIV status in other traditional measures of plaque vulnerability such as the thickness between the atheroma and the lumen or raw atheroma size.
The interpretation of our results becomes more complicated in the context of seemingly contradictory literature. One study indicates that ischemic strokes are more prevalent among immunosuppressed HIV patients, with no correlating additional risk in HIV patients with a CD4 þ cell count above 500 cells/ml [2] . In the context of this study, the greater elastolytic activity in immunocompromised HIV patients might be thought to contribute to the vulnerability of the plaque directly, perhaps thinning fibrous caps. For arteries without atheromas, eroded intima could provide a nidus for clots.
Another study has, however, found that the prevalence of ILAA-related strokes was higher among HIV patients with higher CD4 þ cell counts [10] , which suggests a different possible role for the increased elastolytic activity in immunocompromised HIVþ individuals. Taking into account these studies, the greater elastolytic activity in immunocompromised HIVþ individuals may be thought to lead to remodelling, which manifests in changes that could contribute to the plaque's vulnerability when immunocompetence is regained. The atheromas with more prominent necrotic cores which we found in our study could be an indication of such changes.
Regarding the possible mechanism by which immunocompromised HIVþ individuals were found to have had greater elastolytic activity, it may be that the immune activation which is suspected to deplete CD4 þ cells [28] may also activate elastolytic enzymes. Supporting this idea, TNF-a has been shown to act through MMP-9 to allow vascular smooth muscle cell migration across the internal elastic lamina [29] . Prolonged release of TNF-a present in chronic immune activation could therefore cause elevated MMP-9 levels in the vessels of the immunosuppressed individuals included in our study.
These results should be interpreted in the context of the limitations of this study, which include the use of qualitative measurements for certain variables such as determining if the intima had the strongest staining. This method was used to determine if the strongest staining was found in the intima on stains for caspase 3, MMPs, and TNF-a. Also, though this sample includes 302 study participants, 140 of the participants had atheromas, which restricted numbers for analyses investigating atheroma characteristics. Similarly, the prevalence of brain infarcts due to atherosclerosis was too small to allow multivariate analyses. Also, HIVþ individuals and controls differed in a few characteristics which were found to have effects as covariates. First, there was a marked difference in ethnicity. HIVÀ negative controls were predominantly non-Hispanic White, whereas HIVþ individuals were more often non-Hispanic Black or Hispanic.
Ethnicity was associated with elastolytic score and apoptosis in HIV status, and both HIV status and CD4 þ models, respectively. However, these associations lost statistical significance in models that adjusted for vascular risk factors, which suggest to us that the initial association was mediated by a higher prevalence of vascular risk factor among ethnic minorities with HIV. Furthermore, cocaine use, hepatitis C, and hepatitis B were higher in those with HIV, and the lack of detailed information regarding this confounder in the HIVÀ sample prevents from excluding a role of these factors in modifying the vulnerability noted among those with HIV.
Despite this study's limitations, the BARS is a unique and relatively large sample of age and sex-matched controls for the HIV cases. There is no precedent for the premise and scope of this study. Because of the novelty of the results and limitations discussed above, these results should be used as preliminary evidence for studies of intracranial plaque vulnerability in living individuals with HIV.
Conclusion
HIV and persistent immunosuppression at the time of were associated with a greater degree of elastolysis in the intima of intracranial vessels, potentially leading to more vulnerable plaques or to endothelial erosion and thrombosis. This may help explain the higher stroke incidence in HIV despite a prevalence of atherosclerosis that was no higher in HIVþ individuals.
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